Restricted accessLetterFirst published online 2015-11
Poor outcomes from use of the Artelon® biodegradable implant for the treatment of thumb carpo-metacarpal joint and scapho-trapezio-trapezoid osteoarthritis: a short report and brief review of literature
BellRDesaiSHouseH. A retrospective multicenter study of the Artelon® carpometacarpal joint implant. Hand (NY). 2011, 6: 364–72.
2.
BlountALArmstrongSDYuanF. Porous polyurethaneurea (Artelon) joint spacer compared to trapezium resection and ligament reconstruction. J Hand Surg Am. 2013, 38: 1741–5.
3.
ChoungEWTanV. Foreign-body reaction to the Artelon CMC joint spacer: case report. J Hand Surg Am. 2008, 33: 1617–20.
4.
ClarkeSHagbergWKaufmannRA. Complications with the use of Artelon in thumb CMC joint arthritis. Hand (NY). 2011, 6: 282–6.
5.
DiaoE. Foreign-body reaction to the Artelon CMC joint spacer. J Hand Surg Am. 2009, 34: 1158–9; author reply 1159–60.
6.
GiuffridaAYGyuriczaCPerinoG. Foreign body reaction to artelon spacer: case report. J Hand Surg Am. 2009, 34: 1388–92.
7.
JorheimMIsaxonIFlondellM. Short-term outcomes of trapeziometacarpal artelon implant compared with tendon suspension interposition arthroplasty for osteoarthritis: a matched cohort study. J Hand Surg Am. 2009, 34: 1381–7.
8.
NilssonALiljenstenEBergströmC. Results from a degradable TMC joint spacer (Artelon) compared with tendon arthroplasty. J Hand Surg Am. 2005, 30: 380–9.
9.
NilssonAWiigMAlnehillH. The Artelon CMC spacer compared with tendon interposition arthroplasty. Acta Orthop. 2010, 81: 237–44.
10.
ParkMJLeeATYaoJ. Treatment of thumb carpometacarpal arthritis with arthroscopic hemitrapeziectomy and interposition arthroplasty. Orthopedics. 2012, 35: 1759–64.
11.
RichardMJLunichJACorrellGR. The use of the Artelon CMC spacer for osteoarthritis of the basal joint of the thumb. J Hand Ther. 2014, 27: 122–5.
12.
RobinsonPMMuirLT. Foreign body reaction associated with Artelon: report of three cases. J Hand Surg Am. 2011, 36: 116–20.
